Patent Number | Grant Date | Title | Applicant |
---|---|---|---|
EP3200591 | Sep 25, 2024 | Central Memory T Cells For Adoptive T Cell Therapy | CITY OF HOPE |
EP3294873 | Sep 18, 2024 | Targeting Bcl11A Enhancer Functional Regions For Fetal Hemoglobin Reinduction | MASSACHUSETTS INSTITUTE OF TECHNOLOGY |
EP3056564 | Sep 11, 2024 | Method For Purification Of Retinal Pigment Epithelial Cells | HEALIOS K.K. |
EP3431485 | Sep 4, 2024 | Engineered Nucleic Acids And Methods Of Use Thereof | MODERNATX, INC. |
EP3150699 | Aug 21, 2024 | Culture Medium Containing Uridine And N-Acetyl-D-Mannosamine | JCR PHARMACEUTICALS CO., LTD. |
EP2455479 | Aug 14, 2024 | Disease Resistant Plants | ENZA ZADEN BEHEER B.V. |
EP3011037 | Jun 26, 2024 | Rhizomania-Resistant Gene | KWS SAAT SE |
EP3296395 | Jun 19, 2024 | Multiple Antigen Binding Molecular Fusion, Pharmaceutical Composition, Method For Identifying Linear Epitope, And Method For Preparing Multiple Antigen Binding Molecular Fusion | CHUGAI SEIYAKU KABUSHIKI KAISHA |
EP3622813 | Jun 19, 2024 | Animal Models And Therapeutic Molecules | KYMAB LIMITED |
EP2282764 | Jun 12, 2024 | Liver-Specific Nucleic Acid Regulatory Elements And Methods And Use Thereof | LIFE SCIENCES RESEARCH PARTNERS VZW |
Patent Number | Grant Date | Title | Applicant | Facing Oppositions |
---|---|---|---|---|
EP2800811 | May 10, 2017 | Methods And Compositions For Rna Directed Target Dna Modification And For Rna Directed Modulation Of Transcription | CHARPENTIER, EMMANUELLE | 84 |
EP2791160 | Mar 2, 2022 | Modified Nucleoside, Nucleotide, And Nucleic Acid Compositions | MODERNA THERAPEUTICS, INC. | 80 |
EP3252160 | Oct 28, 2020 | Crispr Cas Component Systems, Methods And Compositions For Sequence Manipulation | THE ROCKEFELLER UNIVERSITY | 50 |
EP3310917 | Feb 12, 2020 | Novel Crispr Enzymes And Systems | MASSACHUSETTS INSTITUTE OF TECHNOLOGY | 48 |
EP3241902 | Feb 28, 2018 | Methods And Compositions For Rna Directed Target Dna Modification And For Rna Directed Modulation Of Transcription | UNIVERSITY OF VIENNA | 48 |
EP3502253 | May 27, 2020 | Novel Crispr Enzymes And Systems | PRESIDENT AND FELLOWS OF HARVARD COLLEGE | 48 |
EP3401400 | Apr 3, 2019 | Methods And Compositions For Rna Directed Target Dna Modification And For Rna Directed Modulation Of Transcription | CHARPENTIER, EMMANUELLE | 48 |
EP3470519 | Feb 12, 2020 | Novel Crispr Enzymes And Systems | MASSACHUSETTS INSTITUTE OF TECHNOLOGY | 48 |
EP2912175 | Aug 22, 2018 | Composition For Cleaving A Target Dna Comprising A Guide Rna Specific For The Target Dna And Cas Protein Encoding Nucleic Acid Or Cas Protein, And Use Thereof | TOOLGEN INCORPORATED | 36 |
EP3494997 | Sep 18, 2019 | Inducible Dna Binding Proteins And Genome Perturbation Tools And Applications Thereof | PRESIDENT AND FELLOWS OF HARVARD COLLEGE | 36 |
Company | Total oppositions filed |
---|---|
STRAWMAN LIMITED | 81 |
JAMES POOLE LIMITED | 70 |
PATENT BOUTIQUE LLP | 50 |
GRUND, DR., MARTIN | 49 |
SCHLICH, GEORGE WILLIAM | 37 |
POHLMAN, SANDRA M. | 35 |
REGENERON PHARMACEUTICALS, INC. | 31 |
CRISPR THERAPEUTICS AG | 27 |
HGF LIMITED | 26 |
PFIZER INC. | 25 |
Feel free to send us a message here and we will get back to you